These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15418789)

  • 1. [Evaluation of our antityphoid vaccine].
    KARAKASEVIC B; JELINEK B
    Vojnosanit Pregl; 1950; 7(1-2):29-45. PubMed ID: 15418789
    [No Abstract]   [Full Text] [Related]  

  • 2. The provisional international standard antityphoid serum.
    FELIX A
    Bull World Health Organ; 1954; 10(6):911-7. PubMed ID: 13199654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of the antityphoid vaccines].
    VIOLLE H
    Biol Med (Paris); 1950; 39(1):1-21. PubMed ID: 15420232
    [No Abstract]   [Full Text] [Related]  

  • 4. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. VIII. SEROLOGICAL REACTIONS IN SUBJECTS VACCINATED WITH VARIOUS ANTITYPHOID VACCINES].
    KOPACKA B; SLUBICKA A
    Przegl Epidemiol; 1963; 17():55-62. PubMed ID: 14053745
    [No Abstract]   [Full Text] [Related]  

  • 5. [The problem of control of antityphoid vaccines. IV. Experimental study of the immunogenic value of antityphoid vaccines tested by various methods].
    GABBRIELLI G; MORGANTETTI F
    Riv Ist Sieroter Ital; 1960; 35():498-504. PubMed ID: 13702758
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mazzetti's method of evaluation of protective efficacy of vaccines; application of control in antityphoid-paratyphoid vaccination].
    FRENI S
    G Med Mil; 1952; 102(3):209-23. PubMed ID: 12989586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statistical measurement of virulence and of immunity: application to the study of typhoid bacteria and to the measurement of immunizing power of antityphoid vaccines].
    BONET-MAURY P; JUDE A; SERVANT P
    Rev Immunol Ther Antimicrob; 1954; 18(1-2):21-49. PubMed ID: 13167818
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebral and meningeal syndromes to antityphoid vaccine].
    STARY O
    Cas Lek Cesk; 1948 Aug; 87(31):865-7. PubMed ID: 18883066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiendotoxin activity of antityphoid vaccines].
    MAZZETTI G; MASSONE F
    Nuovi Ann Ig Microbiol; 1955; 6(3):234-44. PubMed ID: 13266200
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of cortisone and ACTH on the production of specific antibodies in animals immunized with absorbed antityphoid vaccine].
    PARDELLI L; TORRACCA G; TOSI E
    Minerva Pediatr; 1956 Jul; 8(27-28):880-4. PubMed ID: 13369299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serologic response in subjects immunized with antityphoid vaccine].
    Muños O; Alvarez T; Gutiérrez G; Ruiz-Gómez J
    Gac Med Mex; 1975 Apr; 109(4):257-60. PubMed ID: 1140526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estimation of the immunological value of antityphoid vaccines].
    VILOGRON MENDEZ R
    Rev Sanid Mil Peru; 1954; 27(74):35-43. PubMed ID: 13237702
    [No Abstract]   [Full Text] [Related]  

  • 13. [COMPLEMENT ACTIVITY IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL-PROPIONATE].
    LOSCHIAVO F
    Riforma Med; 1964 Nov; 78():1253-4. PubMed ID: 14231517
    [No Abstract]   [Full Text] [Related]  

  • 14. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 15. [PHAGOCYTIC ACTIVITY AND OPSONIC PROPERTY ILEAL TYPHOID CONVALESCENTS GIVEN ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE].
    LOSCHIAVO F
    Riforma Med; 1964 Sep; 78():1056-8. PubMed ID: 14223406
    [No Abstract]   [Full Text] [Related]  

  • 16. [BACTERICIDAL POWER OF THE BLOOD IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE].
    LOSCHIAVO F
    G Mal Infett Parassit; 1965 Feb; 17():59-62. PubMed ID: 14327118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination of chloramphenicol therapy & antityphoid vaccine in the prevention of typhoid fever & paratyphus A].
    KRALJEVIC R; PERRONI J; BOREL H; MOYA H; FLORES L; SALCEDO M
    Rev Med Chil; 1957 Sep; 85(9):525-30. PubMed ID: 13518817
    [No Abstract]   [Full Text] [Related]  

  • 18. Antityphoid and antitetanic intradermal vaccination of chronic neuropsychic patients in a typhoid fever outbreak.
    Dimache G; Croitoru M; Ionescu M; Săvulescu M; Durbacă S; Dimache A
    Roum Arch Microbiol Immunol; 1991; 50(1):37-43. PubMed ID: 1802050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EVALUATION OF THE VACCINE AND EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. 23. AN EPIDEMIC OF TYPHOID FEVER IN GLINOJECK IN 1962-1963].
    SZELAG J; KOSTRUBALA A
    Przegl Epidemiol; 1964; 18():433-8. PubMed ID: 14328146
    [No Abstract]   [Full Text] [Related]  

  • 20. [EVALUATION OF THE VACCINE AND THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. 23. AN EPIDEMIC OF TYPHOID FEVER IN GLINOJECK IN 1962-1963].
    SZELAG J; RZEWUSKA A
    Przegl Epidemiol; 1964; 18():427-31. PubMed ID: 14328145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.